Phoenix Mills shares rally 5% as Motilal Oswal upgrades to ‘Buy’, lifts target price to Rs 2,044
Shares of The Phoenix Mills rallied 5% on Tuesday to an intraday high of Rs 1,597.30 on the BSE after ...
Tag: stock market news
Sunil Singhania-led Abakkus buys equity worth Rs 64 crore in Edelweiss Financial via block deal
Sunil Singhania-led Abakkus Asset Manager Private Limited picked up over 64.3 lakh shares of smallcap Edelweiss Financial Services in a ...
GST rate cut: Car and bike buyers hit pause button as auto stocks rev up for festive bonanza
Indian auto buyers are playing a waiting game, postponing vehicle purchases ahead of an expected GST rate cut that could ...
Nazara Tech shares tumble 18% in 3 sessions on gaming bill jitters; what should investors do now?
Nazara Technologies has slumped 18.25% in just three trading sessions, hitting a low of Rs 1,145.55 on the BSE today, ...
Antique initiates buy call on Zen Technologies shares despite 43% fall in 1 year, sees 31% upside
Brokerage firm Antique Stock Broking has initiated coverage on Zen Technologies for a price target of Rs 1,866, and the ...
Market Trading Guide: Blue Star and a midcap stock are buy recommendations for Tuesday. Up to 6% upside seen – Stock Ideas
Stop loss - 1,856 Target: 2,031BLUESTARCO has witnessed a decisive breakout from a rounding bottom formation on the daily timeframe, ...
Asian Paints shares in focus after 6% fall in Q1 PAT. Should you buy, sell or hold?
Asian Paints is likely to be in the spotlight on Wednesday after the company reported a 6% year-on-year (YoY) decline ...
Adani Energy Q1 Results: Co swings to profit of Rs 512 crore vs YoY loss, revenue grows 27%
Adani Energy Solutions on Thursday reported a consolidated net profit of Rs 512 crore for the June-ended quarter as compared ...
L&T Tech shares in focus after Q1 profit edges up, revenue rises 16% YoY
Shares of L&T Technology Services (LTTS) will be in focus on Thursday after the company reported a marginal 0.7% year-on-year ...
Motilal Oswal sees 28% upside in Glenmark Pharma, hails $700 mln cancer drug deal as ‘new era’ for innovation play
Motilal Oswal has reiterated a “buy” rating on Glenmark Pharmaceuticals with a raised target price of Rs 2,430, implying a ...
